<DOC>
	<DOCNO>NCT01786915</DOCNO>
	<brief_summary>The purpose study ass study medication blood level administration repeat oral capsule ( one capsule day seven day ) Bendavia one two dose level . The effect Bendavia volunteer also assess .</brief_summary>
	<brief_title>Safety Pharmacokinetic ( PK ) Study Oral Bendavia Administered 7 Days</brief_title>
	<detailed_description />
	<criteria>Healthy adult male female age 18 65 year age sign informed consent . Women postmenopausal ( without menstrual bleed &gt; 24 month ) surgically sterile must negative serum pregnancy test screening within 24 hour treatment understanding ( informed consent process ) become pregnant duration study must agree employ effective form birth control duration study . Acceptable form birth control : doublebarrier contraceptive ( condom , diaphragm spermicide ) interuterine device ( IUD ) 1 week prior least 30 day post treatment even hormonal contraceptive use . Serum sodium level lower limit site 's clinical laboratory normal range study qualification visit , Clinically significant laboratory abnormality determine Principal Investigator laboratory screen Creatinine clearance calculate Cockcroft Gault method calculate &lt; 90 mL/min male &lt; 80 mL/min female Clinically significant abnormality physical examination , Body weight less 60 kg great 80 kg body mass index le 18 kg/m2 great 32 kg/m2 , Any disease condition might compromise cardiovascular , hematological , renal , hepatic , pulmonary ( include chronic asthma ) , endocrine ( e.g. , diabetes ) , central nervous , gastrointestinal ( include ulcer ) system , History seizures history epilepsy , History serious ( Principal Investigator judgment ) mental illness , Participant research involve investigational product within 30 day plan date drug administration , Positive serology HIV 1 , HIV 2 , HBsAg , hepatitis C virus ( HCV ) , Fever great 37.5Â°C time plan dosing , Suspicion , recent history , alcohol substance abuse , Donated blood blood product within past 30 day , Women pregnant breastfeeding , Employee family member employee investigational site , Subjects currently smoke cigarette , cigar , pipe chew tobacco product use tobacco product 30 day prior screen , Subjects either unwilling agree refrain use find use : Alcohol , caffeine , xanthinecontaining food beverage , nicotine product overthecounter medication exception Tylenol 24 hour prior dose throughout confinement period Prescription medication 14 day prior 7 day post treatment ( exclude hormonal contraceptive ) Hormonal contraceptive without concomitant use doublebarrier contraceptive ( condom , diaphragm spermicide ) period 7 day prior 30 day post treatment Subjects previous exposure Bendavia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>